This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Yale University. Active years: 2019-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2019-2021
Title: Lindsey Saunders: Innovator in Cancer Treatment
Introduction
Lindsey Saunders is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of therapeutic methods. With a total of 3 patents, her work focuses on stabilizing G-quadruplex DNA to combat tumors.
Latest Patents
One of her latest patents is titled "MYC G-quadruplex stabilizing small molecules and their use." This patent discloses methods for treating both benign and malignant tumors. The methods involve administering a therapeutically effective amount of a small molecule that selectively binds to and stabilizes G-quadruplex DNA in the promoter of the c-MYC gene. This approach aims to decrease the size and/or number of metastases, providing a promising avenue for cancer treatment.
Career Highlights
Throughout her career, Lindsey has worked with notable organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and Yale University. Her work has been instrumental in advancing cancer research and developing new therapeutic strategies.
Collaborations
Lindsey has collaborated with esteemed colleagues such as John K Simmons and John Schneekloth, Jr. These partnerships have further enriched her research and contributed to her success in the field.
Conclusion
Lindsey Saunders is a trailblazer in the realm of cancer treatment, with her innovative patents paving the way for new therapeutic methods. Her dedication to research and collaboration continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile